|
|
|
|
Event raises $16,000 for girl with rare cancer
OTTAWA-A strawberry social for a Navan girl with a rare form of spinal cancer raised $15,550 to help with her care.The Sunday-evening event saw 500 people come to support Morgan Wall, a six-year-old girl with a flair for hockey and dance...
|
|
|
$30K Raised For Officer With Cancer
GALVESTON - A huge benefit staged June 13th for Galveston Police Officer Chris Sanderson could not have been more successful, providing over $30,000 to help the young officer in his battle with cancer.Centered at the Big Amos Restaurant...
|
|
|
PharmaMar bags award from Sarcoma Foundation of America for supporting cure of soft tissue sarcomas
PharmaMar has received the Award 'Supporting A Cure In Our Time' from the Sarcoma Foundation of America (SFA) for its 'support in the search for an effective cure for soft tissue sarcomas', goal of the foundation, during...
|
|
|
Athens man wages battle against rare type of cancer
Will and Emily Haney of Athens are just embarking on careers in public service.Emily, 29, has been director of the Council on Aging for three years and Will, 31, is a year short of completing his nursing degree. When they celebrated...
|
|
|
Boy uses kickball to tackle cancer
Kick It founder Quinn Clarke steals a base as members of the Cleveland Indians look on during a kickball game.Don't miss these Click and choose Statistics, standings, schedules CLEVELAND (AP) -- Quinn Clarke pumped his arms and spun the...
|
|
|
Indians play kickball with kids with cancer
CLEVELAND (AP) - Quinn Clarke pumped his arms and spun the tires on his wheelchair as fast as he could.As he neared third base, he leaped out of the chair and dove headfirst into the bag. The 9-year-old was spinning around Progressive...
|
|
|
Father discusses childhood cancer
I seek recognition of childhood cancer, the No.1 killer of America's children by disease. Each day, seven children are taken from their friends and family. Each day, 46 more children are diagnosed with cancer. Each day, over 35,000...
|
|
|
Student upstages cancer
Hunter Bird overcomes surgeries, radiation and chemotherapy to reach greater heights in the theater department Published: Monday, June 1, 2009 The sky is the limit.If you can dream it, you can do it. Just do it. Do any of these...
|
|
|
Oncolytics Biotech Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting
Oncolytics Biotech Inc.(TSX: ONC, NASDAQ: ONCY) announced that interim results of a Phase II study of intravenous REOLYSIN in patients with sarcomas metastatic to the lung were presented May 30, 2009 at the American Society of...
|
|
|
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present Positive Phase II Sarcoma Trial Results at American Soc
CALGARY, June 1 /PRNewswire-FirstCall/ - announced that interim results of a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung were presented May 30, 2009 at the (ASCO) annual meeting.The...
|
|
|
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meetin
CALGARY, June 1 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.(TSX: ONC, NASDAQ: ONCY) announced that interim results of a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung were presented...
|
|
|
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meetin
CALGARY, June 1 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.(TSX: ONC, NASDAQ: ONCY) announced that interim results of a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung were presented...
|
|
|
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meetin
CALGARY, June 1 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.(TSX: ONC, NASDAQ: ONCY) announced that interim results of a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung were presented...
|
|
|
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meetin
Article Tools Story Tools CALGARY, June 1 /CNW/ - Oncolytics Biotech Inc.(TSX: ONC, NASDAQ: ONCY) announced that interim results of a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung were...
|
|
|
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meetin
Oncolytics Biotech Inc.(TSX: ONC, NASDAQ: ONCY) announced that interim results of a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung were presented May 30, 2009 at the American Society of...
|
|
|
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meetin
CALGARY, June 1 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.(TSX: ONC, NASDAQ: ONCY) announced that interim results of a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung were presented...
|
|
|
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meetin
CALGARY, June 1 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.(TSX: ONC, NASDAQ: ONCY) announced that interim results of a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung were presented...
|
|
|
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meetin
CALGARY, June 1 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.(TSX: ONC, NASDAQ: ONC.) announced that interim results of a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung were presented...
|
|
|
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meetin
CALGARY, June 1 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.(TSX: ONC, NASDAQ: ONCY) announced that interim results of a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung were presented...
|
|
|
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meetin
CALGARY, June 1 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.(TSX:ONC,ONCY) announced that interim results of a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung were presented May 30,...
|
|
|
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meetin
CALGARY, June 1 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.(TSX: ONC, NASDAQ: ONCY) announced that interim results of a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung were presented...
|
|
|
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meetin
CALGARY, June 1 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.(TSX: ONC, NASDAQ: ONCY) announced that interim results of a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung were presented...
|
|
|
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meetin
CALGARY, June 1 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.(TSX: ONC, NASDAQ: ONCY) announced that interim results of a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung were presented...
|
|
|
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meetin
CALGARY, June 1 /CNW/ - Oncolytics Biotech Inc.(TSX: ONC, NASDAQ: ONCY) announced that interim results of a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung were presented May 30, 2009 at...
|
|
|
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meetin
CALGARY, June 1 /PRNewswire-FirstCall/ -- Oncolytics Biotech Inc.(TSX: ONC, NASDAQ: ONCY) announced that interim results of a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung were presented...
|
